SAB Biotherapeutics, Inc. (SABS)
2.95
+0.01
(+0.34%)
USD |
NASDAQ |
Nov 06, 10:10
SAB Biotherapeutics Price : 2.95 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 05, 2026 | 3.24 | 3.24 | 2.91 | 2.94 | 293144.0 |
| Nov 04, 2026 | 3.17 | 3.34 | 3.09 | 3.18 | 1.046M |
| Nov 03, 2026 | 3.31 | 3.365 | 3.09 | 3.12 | 353081.0 |
| Nov 02, 2026 | 3.35 | 3.40 | 3.28 | 3.30 | 487811.0 |
| Oct 30, 2026 | 3.20 | 3.37 | 3.112 | 3.35 | 741051.0 |
| Oct 29, 2026 | 3.23 | 3.36 | 3.16 | 3.23 | 458274.0 |
| Oct 28, 2026 | 3.04 | 3.22 | 3.01 | 3.20 | 347826.0 |
| Oct 27, 2026 | 2.80 | 3.09 | 2.80 | 3.07 | 646573.0 |
| Oct 26, 2026 | 2.82 | 2.94 | 2.765 | 2.79 | 324518.0 |
| Oct 23, 2026 | 2.98 | 3.04 | 2.82 | 2.84 | 1.016M |
| Oct 22, 2026 | 2.83 | 3.08 | 2.83 | 3.04 | 710220.0 |
| Oct 21, 2026 | 2.88 | 2.99 | 2.795 | 2.82 | 388774.0 |
| Oct 20, 2026 | 2.59 | 2.93 | 2.554 | 2.88 | 814536.0 |
| Oct 19, 2026 | 2.53 | 2.645 | 2.44 | 2.60 | 602334.0 |
| Oct 16, 2026 | 2.59 | 2.63 | 2.47 | 2.53 | 756994.0 |
| Oct 15, 2026 | 2.51 | 2.620 | 2.48 | 2.59 | 787938.0 |
| Oct 14, 2026 | 2.64 | 2.72 | 2.45 | 2.49 | 853183.0 |
| Oct 13, 2026 | 2.84 | 2.875 | 2.615 | 2.68 | 893496.0 |
| Oct 12, 2026 | 2.99 | 3.00 | 2.80 | 2.83 | 359062.0 |
| Oct 09, 2026 | 2.905 | 3.02 | 2.81 | 2.98 | 659612.0 |
| Oct 08, 2026 | 2.85 | 2.93 | 2.76 | 2.89 | 1.135M |
| Oct 07, 2026 | 2.90 | 2.965 | 2.81 | 2.88 | 681679.0 |
| Oct 06, 2026 | 3.12 | 3.16 | 2.915 | 2.93 | 663651.0 |
| Oct 05, 2026 | 3.00 | 3.25 | 2.855 | 3.10 | 866272.0 |
| Oct 02, 2026 | 3.10 | 3.12 | 2.96 | 2.98 | 416319.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 57.63 |
| Oncolytics Biotech, Inc. | 0.4545 |
| Sangamo Therapeutics, Inc. | 0.114 |
| Sarepta Therapeutics, Inc. | 17.54 |
| Anixa Biosciences, Inc. | 3.02 |
Price Related Metrics
| Price to Book Value | 1.147 |
| Earnings Yield | -49.07% |
| Market Cap | 246.30M |